2Butera G, De Rosa G, Chessa M, et al. Transcatheter closure of persistent ductus arteriosus with the Amplatzer duct occluder in very young symptomatic children [J]. Heart, 2004, 90: 1467 - 1470.
3Pass RH, Hijazi Z, Hsu DT, et al. Multicenter USA Amplatzer patent ductus arteriosus occlusion device trial: initial and one- year results[J]. J Am Coll Cardiol, 2004, 44:513 - 519.
4Masura J, Gavora P, Podnar T. Transcatheter occlusion of patent ductus arteriosus using a new angled Amplatzer duct occluder: initial clinical experience[J]. Catheter Cardiovasc Interv, 2003, 58:261 - 267.
5Krichenko A, Benson LN, Burrows P, et al. Angiographic classification of the Isolated, persistently patent ductus arteriosus and implications for percutaneous catheter occlusion [J]. Am J Cardiol, 1989, 63:877 - 880.
6Hsin HT, Lin LC, Hwang JJ, et al. Retrograde wire-assisted percutaneous transcatheter closure of persistent ductus arteriosus with Amplatzer duct occluder in the elderly: A new application [J]. Catheter Cardiovasc Interv, 2004, 61 : 264 - 271.
7Thanopoulos BD, Tsaousis GS, Djukic M, et al. Transcatheter closure of high pulmonary artery pressure persistent ductusarteriosus with the Amplatzer muscular ventricular septal defect occluder[J]. Heart, 2002, 87: 260- 263.
9Diller GP, Dimopoulos K, Okonko D, et al. Exercise intolerance inadultcongenitalheartdisease: comparative severity, correlates, and prognostic implication. Circulation, 2005, 112:828-835.
10Heath D, Edwards JE. The pathology of hypertensive pulmonary vascular disease:a description of six grades of structural changes in the pulmonary arteries with special reference to congenital heart defect. Circulation, 1985, 18:533-547.
